COR — Cencora, Inc.
—
NYSE ·
Consumer Discretionary ·
Distributors ·
CIK 1140859 ·
Last close
$286.13
Market Cap
$55.67B
52W High
$327.24
52W Low
$244.26
ADV30
1,751,643
Next earnings
2026-08-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 85,932,016,000 | 3,072,071,000 | 1,016,381,000 | 559,647,000 | 78,361,214,000 | 1,753,122,000 | 76,265,246,000 |
| Sep 2025 | 83,728,554,000 | 2,953,577,000 | 945,941,000 | -339,704,000 | 76,590,112,000 | 4,356,138,000 | 74,843,027,000 |
| Jun 2025 | 80,663,532,000 | 2,907,115,000 | 980,239,000 | 687,402,000 | 73,956,905,000 | 2,231,852,000 | 71,747,014,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$4,288,733,000
Investing CF
$-4,933,569,000
Financing CF
$-916,832,000
CapEx
$-681,464,000
Dividends Paid
$-452,709,000
Buybacks
$-50,000,000
EPS Diluted TTM
$13.04
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$6,967,358,000
Inventory
$24,078,494,000
Receivables
$25,979,920,000
ST Investments
—
EBIT TTM
$1,737,490,000
Pretax Income TTM
$1,417,873,000
Interest Exp TTM
$319,617,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$328,680,013,824
EBITDA
$5,300,438,016
Free Cash Flow
$-318,246,112
Enterprise Value
$68,772,732,928
Total Cash
$2,176,496,128
Total Debt
$15,092,111,360
Shares Out
194,561,060
Trailing EPS
$13.05
Book Value
$17.46
ROE
107.1%
ROA
3.5%
Div Yield
0.84%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 321,332,819,000 | 3,933,622,000 | 1,554,169,000 | 76,590,112,000 | 74,843,027,000 | — | 3,875,120,000 |
| Sep 2024 | 293,958,599,000 | 3,156,949,000 | 1,509,120,000 | 67,101,667,000 | 66,314,925,000 | — | 3,484,685,000 |
| Sep 2023 | 262,173,411,000 | 2,685,605,000 | 1,745,293,000 | 62,558,746,000 | 61,892,459,000 | — | 3,911,334,000 |
| Sep 2022 | 238,587,006,000 | 2,753,510,000 | 1,698,820,000 | 56,560,616,000 | 56,489,343,000 | — | 2,703,088,000 |
TTM Snapshot
Revenues TTM
$282,740,057,000
NetIncome TTM
$1,858,608,000
OpCashFlow TTM
$0
Assets (Latest)
$76,590,112,000
Forward EPS
$19.79
Max Pain — expiry 2027-01-15
max pain strike: $340.00 · spot: $287.02 · call oi: 2,600 · put oi: 783
Expected Move to 2027-01-15:
±$59.85
(20.85%) —
implied range
$227.17 –
$346.87
· ATM straddle on $290.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CAH | CARDINAL HEALTH INC | $55.72B | $237.92 | — |
| TEL | TE Connectivity plc | $57.72B | $197.74 | — |
| GWW | W.W. GRAINGER, INC. | $63.91B | $1353.61 | — |
| FERG | Ferguson Enterprises Inc. /DE/ | $46.28B | $238.61 | — |
| SYY | SYSCO CORP | $39.60B | $82.82 | — |
News headlines (Yahoo Finance, 1h cache)
Cencora (COR) Stock After Recent Pullback And DCF Valuation Gap
2026-06-29 11:07 · Yahoo
Cencora (COR) Launches Nucleus Pilot As Verizon Executive Joins As CHRO
2026-06-28 18:05 · Yahoo
3 Big Reasons to Love Cencora (COR)
2026-06-26 19:04 · Yahoo
2 Large-Cap Stocks Worth Your Attention and 1 We Brush Off
2026-06-26 09:20 · Yahoo
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?
2026-06-25 21:15 · Yahoo
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
2026-06-23 23:53 · Yahoo
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?
2026-06-19 17:10 · Yahoo
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?
2026-06-19 12:36 · Yahoo
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?
2026-06-18 16:49 · Yahoo
Cencora Launches Enhanced Nucleus Solution for Specialty Practices
2026-06-18 14:33 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-06-24 16:04:15 | 2026-06-22 | Tyler Lauren M | Dir | P - Purchase | 270.23 | 550 | 148627 |
| 2026-06-22 16:05:32 | 2026-06-18 | Durcan Dermot Mark | Dir | P - Purchase | 274.19 | 4000 | 1096760 |